Cytokeratin expression in hematological neoplasms: A tissue microarray study on 866 lymphoma and leukemia cases

Pathology Research and Practice

Volumn 204, Issue 8, 2008, Pages 569-573

  Adams, Heiner ^a   Schmid, Patrik ^a   Dirnhofer, Stephan ^a   Tzankov, Alexandar ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Aberrant expression; Cytokeratins; Malignant lymphoma; Tissue microarray

Indexed keywords

CYTOKERATIN; CYTOKERATIN 22; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; PERIPHERAL T CELL LYMPHOMA; PLASMACYTOMA; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; EUROPE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; TISSUE ARRAY ANALYSIS;

EID: 47149086403     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.02.008     Document Type: Article

References (22)

1. de Mascarel A., Merlio J.P., Coindre J.M., et al. Gastric large cell lymphoma expressing cytokeratin but no leukocyte common antigen. A diagnostic dilemma. Am J. Clin. Pathol. 91 (1989) 478-481
2. Eusebi V., Carcangiu M.L., Dina R., et al. Keratin-positive epithelioid angiosarcoma of thyroid. A report of four cases. Am. J. Surg. Pathol. 14 (1990) 737-747
3. Frierson H.F., Bellafiore F.J., Gaffey M.J., et al. Cytokeratin in anaplastic large cell lymphoma. Mod. Pathol. 7 (1994) 317-321
4. Gustmann C., Altmannsberger M., Osborn M., et al. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am. J. Pathol. 138 (1991) 1413-1422
5. Jaffe E.S., Harris N.L., Stein H., et al. Pathology & Genetics - Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon
6. Knapp A.C., and Franke W.W. Spontaneous losses of control of cytokeratin gene expression in transformed non-epithelial human cells occurring at different levels of regulation. Cell 59 (1989) 67-79
7. Lasota J., Hyjek E., Koo C.H., et al. Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am. J. Surg. Pathol. 20 (1996) 346-354
8. Martinez N., Camacho F.I., Algara P., et al. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival. Cancer Res. 63 (2003) 8226-8232
9. McCluggage W.G., El-Agnaff M., and O'Hara M.D. Cytokeratin positive T cell malignant lymphoma. J. Clin. Pathol. 51 (1998) 404-406
10. Miettinen M., and Franssila K. Immunohistochemical spectrum of malignant melanoma. the common presence of keratins. Lab. Invest. 61 (1989) 623-628
11. Miettinen M., and Rapola J. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors. Expression of cytokeratin and the 68-kD neurofilament protein. Am. J. Surg. Pathol. 13 (1989) 120-132
12. Pankov R., Umezawa A., Maki R., et al. Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc. Natl. Acad. Sci. USA 91 (1994) 873-877
13. Petruch U.R., Horny H.P., and Kaiserling F. Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed paraffin-embedded tissue. Histopathology 20 (1992) 35-40
14. Sewell H.F., Thompson W.D., and King D.J. IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin. Br. J. Cancer 53 (1986) 695-696
15. Shin J.S., Stopyra G.A., Warhol M.J., et al. Plasmacytoma with aberrant expression of myeloid markers T-cell markers, and cytokeratin. J. Histochem. Cytochem. 49 (2001) 791-792
16. Traweek S.T., Liu J., and Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am. J. Pathol. 142 (1993) 1111-1118
17. Tzankov A., Gschwendtner A., Augustin F., et al. Diffuse large B-cell lymphoma with overexpression of cyclin E substantiates poor standard treatment response and inferior outcome. Clin. Cancer Res. 12 (2006) 2125-2132
18. Tzankov A., Heiss S., Ebner S., et al. Angiogenesis in nodal B cell lymphomas: a high throughput study. J. Clin. Pathol. 60 (2007) 476-482
19. + regulatory T-cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin lymphoma. Haematologica 93 (2008) 193-200
20. Tzankov A., Went P., Zimpfer A., et al. Tissue microarray technology: principles pitfalls and perspectives - lessons learned from hematological malignancies. Exp. Gerontol. 40 (2005) 737-744
21. Tzankov A., Zimpfer A., Pehrs A.C., et al. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod. Pathol. 16 (2003) 1141-1147
22. Wotherspoon A.C., Norton A.J., and Isaacson P.G. Immunoreactive cytokeratins in plasmacytomas. Histopathology 14 (1989) 141-150